Trial Profile
A Randomised, Double-blind, Placebo-Controlled, Phase II Study to Assess the Efficacy and Safety of Topically Applied DGLA Cream in Patients with Mild to Moderate Acne Vulgaris
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Mar 2017
Price :
$35
*
At a glance
- Drugs Diroleuton (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors DS Biopharma
- 14 Dec 2015 New trial record